Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Insulin soluble porcine 100units/mL injection 1.5mL cartridge (product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Porcine insulin soluble |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Porcine insulin soluble-containing product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Porcine insulin soluble |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Porcine insulin soluble-containing product in parenteral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Porcine insulin soluble |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely pork insulin (as porcine insulin soluble) 1000 unit/10 milliliter conventional release solution for injection vial |
Has precise active ingredient |
False |
Porcine insulin soluble |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Porcine insulin soluble only product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Porcine insulin soluble |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Porcine insulin soluble only product in parenteral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Porcine insulin soluble |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely pork insulin (as porcine insulin soluble) 100 unit/1 milliliter conventional release solution for injection (clinical drug) |
Has precise active ingredient |
False |
Porcine insulin soluble |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Porcine insulin soluble 30 unit/mL and porcine isophane insulin 70 unit/mL suspension for injection |
Has precise active ingredient |
True |
Porcine insulin soluble |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Porcine insulin soluble 30 unit/mL and porcine isophane insulin 70 unit/mL suspension for injection |
Has basis of strength substance (attribute) |
True |
Porcine insulin soluble |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Product containing precisely porcine regular insulin 100 unit/1 milliliter conventional release solution for injection (clinical drug) |
Has precise active ingredient |
True |
Porcine insulin soluble |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely porcine regular insulin 100 unit/1 milliliter conventional release solution for injection (clinical drug) |
Has basis of strength substance (attribute) |
True |
Porcine insulin soluble |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Isophane insulin- and porcine regular insulin-containing product in parenteral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Porcine insulin soluble |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Product containing isophane insulin and porcine regular insulin (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Porcine insulin soluble |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Product containing only isophane insulin and porcine regular insulin (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Porcine insulin soluble |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Product containing only isophane insulin and porcine regular insulin in parenteral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Porcine insulin soluble |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Porcine insulin soluble- and porcine isophane insulin-containing product in parenteral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Porcine insulin soluble |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Porcine insulin soluble and porcine isophane insulin only product in parenteral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Porcine insulin soluble |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Porcine insulin soluble- and porcine isophane insulin-containing product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Porcine insulin soluble |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Product containing only porcine isophane insulin and porcine regular insulin (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Porcine insulin soluble |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |